ACELRX PHARMACEUT. DL-01 (R5XA) — Defensive Interval Ratio
ACELRX PHARMACEUT. DL-01 (R5XA) has a Defensive Interval Ratio of 1388 days as of December 2025. Defensive assets of €14.49 Million (cash €-, short-term investments €14.49 Million, receivables €-) cover 1388 days of daily cash needs of €10.44K/day. See R5XA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ACELRX PHARMACEUT. DL-01 Defensive Interval Ratio (2021–2025)
This chart shows how ACELRX PHARMACEUT. DL-01's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 1388 days, meaning defensive assets of €14.49 Million can fund 1388 days of operations without new revenue. See ACELRX PHARMACEUT. DL-01 balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for ACELRX PHARMACEUT. DL-01 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for ACELRX PHARMACEUT. DL-01 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is ACELRX PHARMACEUT. DL-01 worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1388 days | €14.49 Million | €10.44K/day | €- | €14.49 Million | ▲ +1388 days |
| 2024 | 0 days | €0.00 | €7.25K/day | €- | €0.00 | ▼ -296 days |
| 2023 | 296 days | €3.66 Million | €12.36K/day | €- | €3.66 Million | ▲ +275 days |
| 2022 | 21 days | €804.00K | €37.73K/day | €- | €495.00K | ▼ -750 days |
| 2021 | 772 days | €39.13 Million | €50.71K/day | €- | €38.97 Million | — |